| Literature DB >> 35048054 |
André Caroli Rocha1, Felipe Paiva Fonseca2, Alan Roger Santos-Silva2, Silvia Vanessa Lourenço3, Marcelo Minharro Ceccheti1, Jayro Guimarães Júnior1.
Abstract
Ameloblastoma is a benign, but locally aggressive odontogenic neoplasm, whose appropriate therapeutic management remains highly debatable. The aim of this study was to evaluate the reliability and effectiveness of the two conservative surgical therapeutic protocols (curettage with peripheral ostectomy only and curettage plus cryotherapy) for the management of ameloblastomas. About 53 cases of the ameloblastomas treated in 9 years were retrospectively analyzed regarding their clinical, histopathologic, radiographic, and therapeutic data. The results and the postoperative complications related to both the therapeutic protocols were also statistically investigated. A slight female preponderance was seen (1.12:1.0) with a mean age of 27.1 years. The posterior mandible was the most affected site and dental involvement was frequently found. Multilocular lesions causing the alterations of the bone cortices were the most common radiographic findings. Recurrences were seen in 9.4% of the cases and although the patients submitted to curettage plus cryotherapy have shown an increased incidence of wound dehiscence, infection, and paresthesia, only bone sequestration proved to be significantly more frequent in this group compared to the patients treated by curettage with peripheral ostectomy only. The incidence of the recurrences following the conservative management is low and cryotherapy use as an adjuvant tool must be rationally considered.Entities:
Keywords: ameloblastoma; cryotherapy; curettage; odontogenic tumors; treatment
Year: 2021 PMID: 35048054 PMCID: PMC8757795 DOI: 10.3389/froh.2021.737424
Source DB: PubMed Journal: Front Oral Health ISSN: 2673-4842
Clinicopathological, radiographic, and therapeutic features of the patients affected by the ameloblastoma.
|
|
| ||
|---|---|---|---|
| Sex | Male | 25 | 47.2 |
| Female | 28 | 52.8 | |
| Mean age | 27.1 years (±13.8 years) | ||
| Location | Posterior mandible | 40 | 75.5 |
| Anterior mandible | 4 | 7.6 | |
| Anterior and posterior mandible | 5 | 9.4 | |
| Maxilla | 3 | 5.7 | |
| Soft tissue | 1 | 1.9 | |
| Clinic presentation | Swelling | 34 | 64.2 |
| Swelling + pain | 12 | 22.6 | |
| Radiographic finding | 7 | 13.2 | |
| Radiographic presentation | Unilocular | 17 | 32.7 |
| Multilocular | 35 | 67.3 | |
| Cortical involvement | |||
| Expanded | 5 | 9.6 | |
| Perforated | 1 | 1.9 | |
| Expanded + Perforated | 44 | 84.6 | |
| Preserved | 2 | 3.8 | |
| Expanded | 25 | 51 | |
| Perforated | 0 | 0.0 | |
| Expanded + Perforated | 3 | 6.1 | |
| Preserved | 21 | 42.8 | |
| Dental involvement |
| ||
| Yes | 39 | 73.6 | |
| No | 14 | 26.4 | |
|
| |||
| Yes | 36 | 67.9 | |
| No | 17 | 32.1 | |
|
| |||
| Yes | 20 | 37.7 | |
| No | 33 | 62.3 | |
| Microscopic findings | Follicular | 17 | 32.1 |
| Plexiform | 17 | 32.1 | |
| Mixed | 11 | 20.8 | |
| Basal cell | 1 | 1.9 | |
| Acanthomatous | 1 | 1.9 | |
| Unicystic | 6 | 11.3 | |
| Previous treatment | Yes | 17 | 32.1 |
| No | 36 | 67.9 | |
| Treatment modality | Curettage | 18 | 33.9 |
| Curettage + Cryotherapy | 30 | 56.6 | |
| Mandibulectomy | 4 | 7.6 | |
| Soft tissue resection | 1 | 1.9 | |
In this case, the lesion was located in the soft tissue of a patient previously submitted to the resection of the tumor.
Frequency of the post-operative complications, time of follow-up, and incidence of the recurrences according to the therapeutic modality used.
|
|
|
|
| |
|---|---|---|---|---|
| Post-operatory side effect | ||||
| Dehiscence | 16 (88.9%) | 26 (86.7%) | 0 (0.0%) | 0 (0.0%) |
| Infection | 1 (5.6%) | 5 (16.7%) | 0 (0.0%) | 0 (0.0%) |
| Transitory paresthesia | 10 (55.6%) | 17 (56.7%) | 0 (0.0%) | 0 (0.0%) |
| Permanent paresthesia | 4 (22.2%) | 10 (33.3%) | 4 (100%) | 0 (0.0%) |
| Pathologic fracture | 0 (0.0%) | 6 (20%) | 0 (0.0%) | 0 (0.0%) |
| Bone sequestrum | 1 (5.6%) | 12 (40%) | 0 (0.0%) | 0 (0.0%) |
| Facial asymmetry | 2 (11.1%) | 3 (10%) | 4 (100%) | 1 (100%) |
| Time of follow-up | 55.5 (±26.8) | 69.7 (±27.6) | 74.2 (±34.2) | 104.8 |
| Recurrences | 1 (5.6%) | 3 (10%) | 0 (0.0%) | 1 (100%) |
Statistically significant difference between the curettage and curettage plus cryotherapy (p = 0.017);
months.
Figure 1Patients in this study revealed a high disease-free survival rate measured by the Kaplan–Meier curve reaching almost 90% after 5 years of follow-up.